Literature DB >> 7420580

Inappropriate antidiuretic hormone secretion after high dose vinblastine.

A Antony, W A Robinson, C Roy, W Pelander, R Donohue.   

Abstract

We report on a patient with an embryonal teratocarcinoma of the testicle who had the syndrome of inappropriate secretion of antidiuretic hormone after receiving a high dose of vinblastine. His clinical course and laboratory studies are discussed. We suggest that patients receiving a high dose of vinblastine are at risk for the development of this syndrome.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7420580     DOI： 10.1016/s0022-5347(17)56132-7

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


  5 in total

1.  Life-threatening hyponatremia caused by vinblastine.

Authors:  G Zavagli; G Ricci; G Tataranni; G Mapelli; V Abbasciano
Journal:  Med Oncol Tumor Pharmacother       Date:  1988

Review 2.  Hyponatremia related to medical anticancer treatment.

Authors:  T Berghmans
Journal:  Support Care Cancer       Date:  1996-09       Impact factor: 3.603

3.  Syndrome of inappropriate ADH secretion secondary to vinblastine.

Authors:  R A Stahel; O Oelz
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

Review 4.  Drug-induced syndrome of inappropriate antidiuretic hormone secretion. Causes, diagnosis and management.

Authors:  T Y Chan
Journal:  Drugs Aging       Date:  1997-07       Impact factor: 3.923

5.  Syndrome of inappropriate antidiuretic hormone secretion following irinotecan-cisplatin administration as a treatment for recurrent ovarian clear cell carcinoma.

Authors:  Do Youn Kwon; Gwan Hee Han; Roshani Ulak; Kyung Do Ki; Jong Min Lee; Seon Kyung Lee
Journal:  Obstet Gynecol Sci       Date:  2017-01-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.